AUA2025: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice
AUAUniversity4 Jun 2025

AUA2025: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice

AUA2025: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice CME Available: https://auau.auanet.org/node/43015 At the conclusion of this activity, participants will be able to: 1. Describe key components of genetic risk assessment, genetic counseling, and informed consent for genetic testing. 2. Describe elements of genetic test reports including variant classification, variant allele frequency, gene penetrance, biomarkers, and clinical actionability. 3. Identify criteria for genetic testing for men with prostate cancer. Understand the clinical implications of genetic results in prostate cancer screening and management of both localized and advanced prostate cancer. 4. Describe genetic causes, clinical manifestations, indication for genetic testing, and cancer risk associated with hereditary kidney cancer syndromes. Understand how genetic mutation can guide targeted therapy in patients with von Hippel-Lindau syndrome. 5. Recognize genetic causes, tumor features, and cancer risk associated with Lynch syndrome and apply gained knowledge to improve care of patients with upper tract urothelial carcinoma. ACKNOWLEDGEMENTS: This educational activity is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Novartis Pharmaceuticals Corporation, Pfizer, Inc.

Episoder(421)

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

AUA2016 Presidential Address: US Healthcare Reform: Past, Present, and Future

2016 AUA Annual Meeting Presidential Address William F. Gee, MD Lexington, KY

8 Jan 202020min

Targeted Therapies In Renal Cell Carcinoma

Targeted Therapies In Renal Cell Carcinoma

Co-Host: Jay Raman, MD, FACS At the conclusion of these activities, participants will be able to: 1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of...

24 Des 201933min

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual p...

18 Des 201937min

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Sequencing Of Agents And Combination of Treatment Options for Renal Cell Carcinoma

Co-Host: Brian M. Shuch, MD At the conclusion of these activities, participants will be able to: 1. Describe a patient-specific treatment plan that optimizes the use of targeted and immunological age...

11 Des 201927min

Adjuvant Therapy in Renal Cell Carcinoma

Adjuvant Therapy in Renal Cell Carcinoma

Co-Host: Alexander Kutikov, MD, FACS At the conclusion of these activities, participants will be able to: 1. Discuss the evolving landscape of adjuvant therapy for the treatment of RCC. 2. Identify b...

4 Des 201932min

Comorbidities in Advanced Prostate Cancer

Comorbidities in Advanced Prostate Cancer

Co-Host: Alicia K. Morgans, MD, MPH At the conclusion of these activities, participants will be able to: 1. Recognize cardiovascular comorbidities and describe their management in the context of pros...

27 Nov 201928min

Genetic Testing in Prostate Cancer

Genetic Testing in Prostate Cancer

Co-Host: Brian Shuch, MD At the conclusion of these activities, participants will be able to: 1. State the criteria for genetic testing of prostate cancer patients, the gene panels available, and opt...

18 Nov 201925min

Chemo-ablation of Upper-Tract Urothelial Carcinoma

Chemo-ablation of Upper-Tract Urothelial Carcinoma

Co-Host: Vitaly Margulis, MD At the conclusion of these activities, participants will be able to: 1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks and bene...

13 Nov 201924min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
foreldreradet
jakt-og-fiskepodden
rss-strid-de-norske-borgerkrigene
smart-forklart
rss-sunn-okonomi
merry-quizmas
sinnsyn
gravid-uke-for-uke
fryktlos
hverdagspsyken
aldring-og-helse-podden
rss-adhd-i-klasserommet
rss-kunsten-a-leve
rss-mann-i-krise-med-sagen
rss-impressions-2
rss-kull